| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alexander Denner | 10%+ Owner | $99,127,497 | 04 Mar 2025 | ||
| Pavel Raifeld | 10%+ Owner | $2,938,818 | 03 Nov 2025 | ||
| Jules Haimovitz | Director | $2,626,612 | 19 May 2025 | ||
| Mark DiPaolo | Director | $2,402,376 | 19 May 2025 | ||
| Sarah Schlesinger | Director | $2,402,376 | 19 May 2025 | ||
| George Bickerstaff | Director | $2,202,172 | 25 Apr 2022 | ||
| Kostas D. Odysseas | Director | $1,977,941 | 17 Jun 2024 | ||
| Stephen Basso | Chief Financial Officer | $1,084,598 | 20 Nov 2025 | ||
| Marianne Zhen | Chief Accounting Officer | $1,022,810 | 20 Nov 2025 | ||
| Deborah Birx | Director | $946,693 | 22 May 2023 | ||
| Sapna Srivastava | Director | $711,268 | 17 Jun 2024 | ||
| Matthew Ronsheim | Officer | $653,426 | 20 May 2024 | ||
| Derek Small | Director | $647,876 | 19 May 2025 | ||
| GSK plc | 10%+ Owner | 20 May 2021 | |||
| Margaret Koziel | Chief Medical Officer | 31 Jul 2023 | |||
| Larry Edwards | CEO of La Jolla Pharmaceutical | 22 Aug 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|